Perindopril improves six minute walking distance in older patients with left ventricular systolic dysfunction: a randomised double blind placebo controlled trial

Controlled Trial ◽

Systolic Dysfunction ◽

Left Ventricular ◽

Walking Distance ◽

Double Blind ◽

Double Blind Placebo

Faculty Opinions recommendation of Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1122755.579832 ◽

2008 ◽

Author(s):

Wolfgang Schoels

Keyword(s):

Coronary Artery Disease ◽

Controlled Trial ◽

Systolic Dysfunction ◽

Left Ventricular ◽

Double Blind ◽

Double Blind Placebo ◽

Rationale and design of a randomized, double-blind, placebo-controlled trial of ivabradine in patients with stable coronary artery disease and left ventricular systolic dysfunction: the morBidity-mortality EvAlUaTion of the If inhibitor ivabradine in patients with coronary disease and left ventricULar dysfunction (BEAUTIFUL) Study

American Heart Journal ◽

10.1016/j.ahj.2006.01.013 ◽

2006 ◽

Vol 152 (5) ◽

pp. 860-866 ◽

Cited By ~ 59

Author(s):

Kim Fox ◽

Roberto Ferrari ◽

Michal Tendera ◽

Philippe Gabriel Steg ◽

Ian Ford

Keyword(s):

Ventricular Dysfunction ◽

Controlled Trial ◽

Systolic Dysfunction ◽

Left Ventricular ◽

Double Blind ◽

Double Blind Placebo ◽

Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial

The Lancet ◽

10.1016/s0140-6736(08)61170-8 ◽

2008 ◽

Vol 372 (9641) ◽

pp. 807-816 ◽

Cited By ~ 694

Author(s):

Kim Fox ◽

Ian Ford ◽

P Gabriel Steg ◽

Michal Tendera ◽

Roberto Ferrari

Keyword(s):

Coronary Artery Disease ◽

Controlled Trial ◽

Systolic Dysfunction ◽

Left Ventricular ◽

Double Blind ◽

Double Blind Placebo ◽

Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial

Yearbook of Cardiology ◽

10.1016/s0145-4145(09)79536-x ◽

2009 ◽

Vol 2009 ◽

pp. 279-282

Author(s):

B.J. Gersh

Keyword(s):

Coronary Artery Disease ◽

Controlled Trial ◽

Systolic Dysfunction ◽

Left Ventricular ◽

Double Blind ◽

Double Blind Placebo ◽

Effects of ivabradine on cardiovascular events in patients with moderate to severe chronic heart failure and left ventricular systolic dysfunction. A three-year randomised double-blind placebo-controlled international multicentre study

http://isrctn.org/> ◽

10.1186/isrctn70429960 ◽

2012 ◽

Author(s):

Karl Swedberg

Keyword(s):

Heart Failure ◽

Chronic Heart Failure ◽

Multicentre Study ◽

Cardiovascular Events ◽

Systolic Dysfunction ◽

Left Ventricular ◽

Double Blind ◽

Double Blind Placebo

Faculty Opinions recommendation of Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.1120774.597955 ◽

2009 ◽

Author(s):

Brian Olshansky

Keyword(s):

Coronary Artery Disease ◽

Heart Rate ◽

Risk Factor ◽

Controlled Trial ◽

Systolic Dysfunction ◽

Left Ventricular ◽

Artery Disease ◽

Randomised Controlled

838-1 National patterns of spironolactone prescription for older patients with heart failure and left ventricular systolic dysfunction before and after RALES

Journal of the American College of Cardiology ◽

10.1016/s0735-1097(04)91750-0 ◽

2004 ◽

Vol 43 (5) ◽

pp. A415

Author(s):

Frederick A Masoudi ◽

Cary P Gross ◽

Yongfei Wang ◽

Edward P Havranek ◽

Saif S Rathore ◽

...

Keyword(s):

Heart Failure ◽

Older Patients ◽

Systolic Dysfunction ◽

Left Ventricular ◽

Patients With Heart Failure ◽

Before And After

Cardiorespiratory Requirements of the 6-Min Walk Test in Older Patients with Left Ventricular Systolic Dysfunction and No Major Structural Heart Disease

International Journal of Sports Medicine ◽

10.1055/s-2007-964886 ◽

2007 ◽

Vol 28 (8) ◽

pp. 678-684 ◽

Cited By ~ 9

Author(s):

L. Ingle ◽

M. Wilkinson ◽

S. Carroll ◽

C. Boyes ◽

R. Butterly ◽

...

Keyword(s):

Heart Disease ◽

Older Patients ◽

Systolic Dysfunction ◽

Structural Heart Disease ◽

Left Ventricular ◽

Walk Test ◽

Ventricular Systolic Dysfunction

Zofenopril and Ramipril in Combination with Acetyl Salicylic Acid in Postmyocardial Infarction Patients with Left Ventricular Systolic Dysfunction: A Retrospective Analysis of the SMILE-4 Randomized, Double-Blind Study in Diabetic Patients

Cardiovascular Therapeutics ◽

10.1111/1755-5922.12175 ◽

2016 ◽

Vol 34 (2) ◽

pp. 76-84 ◽

Cited By ~ 3

Author(s):

Claudio Borghi ◽

Stefano Omboni ◽

Salvatore Novo ◽

Dragos Vinereanu ◽

Giuseppe Ambrosio ◽

...

Keyword(s):

Salicylic Acid ◽

Retrospective Analysis ◽

Systolic Dysfunction ◽

Left Ventricular ◽

Diabetic Patients ◽

Double Blind Study ◽

Double Blind ◽

Postmyocardial Infarction

Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial

The Lancet ◽

10.1016/s0140-6736(08)61171-x ◽

2008 ◽

Vol 372 (9641) ◽

pp. 817-821 ◽

Cited By ~ 523

Author(s):

Kim Fox ◽

Ian Ford ◽

P Gabriel Steg ◽

Michal Tendera ◽

Michele Robertson ◽

...

Keyword(s):

Coronary Artery Disease ◽

Heart Rate ◽

Risk Factor ◽

Controlled Trial ◽

Systolic Dysfunction ◽

Left Ventricular ◽

Artery Disease ◽

Randomised Controlled